Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The optimal treatment of hyperglycemia in general surgical patients with type 2 diabetes mellitus is not known. RESEARCH DESIGN AND METHODS: This randomized multicenter trial compared the safety and efficacy of a basal-bolus insulin regimen with glargine once daily and glulisine before meals (n = 104) to sliding scale regular insulin (SSI) four times daily (n = 107) in patients with type 2 diabetes mellitus undergoing general surgery. Outcomes included differences in daily blood glucose (BG) and a composite of postoperative complications including wound infection, pneumonia, bacteremia, and respiratory and acute renal failure. RESULTS: The mean daily glucose concentration after the 1st day of basal-bolus insulin and SSI was 145 ± 32 mg/dL and 172 ± 47 mg/dL, respectively (P < 0.01). Glucose readings <140 mg/dL were recorded in 55% of patients in basal-bolus and 31% in the SSI group (P < 0.001). There were reductions with basal-bolus as compared with SSI in the composite outcome [24.3 and 8.6%; odds ratio 3.39 (95% CI 1.50–7.65); P = 0.003]. Glucose <70 mg/dL was reported in 23.1% of patients in the basal-bolus group and 4.7% in the SSI group (P < 0.001), but there were no significant differences in the frequency of BG <40 mg/dL between groups (P = 0.057). CONCLUSIONS: Basal-bolus treatment with glargine once daily plus glulisine before meals improved glycemic control and reduced hospital complications compared with SSI in general surgery patients. Our study indicates that a basal-bolus insulin regimen is preferred over SSI in the hospital management of general surgery patients with type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As discussed in Q12. How can glycemic targets be achieved in persons with T2D? as well as in the AACE Comprehensive Type 2 Diabetes Management Algorithm,73 some newer therapies carry a lower risk of hypoglycemia, which may enable more persons to safely achieve individualized target A1C levels.69,88–90”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A randomized controlled trial has shown that basal plus bolus insulin plan improved glycemic outcomes and reduced hospital complications compared with a correction or supplemental insulin without basal insulin (formerly known as sliding scale) for people with type 2 diabetes admitted for general surgery (74).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“In individuals undergoing noncardiac general surgery, basal insulin plus premeal short-or rapid-acting insulin (basal-bolus) coverage has been associated with improved glycemic outcomes and lower rates of perioperative complications compared with the reactive, correction-only short-or rapid-acting insulin coverage alone with no basal insulin dosing (74,145).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Intensive glucose control (A1C levels <7% in T2D and <7.5% in T1D) in several clinical trials was found to reduce the risk of incident albuminuria (A2) and DKD onset.70,78,90,406–410”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [90]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 1×
“…setting, observational and prospective clinical trials have shown that hyper-glycemia is associated with increased rates of hospital complications and mortality (8,10,11) and that improved glycemic control reduces multiorgan failure, systemic infections, and short-and long-term mortality (7,8).”
BackgroundHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Furnary, A. P., Gao, G., Grunkemeier, G. L., Wu, Y., Zerr, K. J., Bookin, S. O., Floten, H. S., & Starr, A. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.181 · Cited by 1,130
Lazar, H. L., Chipkin, S. R., Fitzgerald, C. A., Bao, Y., Cabral, H., & Apstein, C. S. (2004) · Circulation · doi:10.1161/01.cir.0000121747.71054.79 · Cited by 717
Early Postoperative Glucose Control Predicts Nosocomial Infection Rate in Diabetic Patients
Pomposelli, J. J., Baxter, J. K., Babineau, T. J., Pomfret, E. A., Driscoll, D. F., Forse, R. A., & Bistrian, B. R. (1998) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719802200277 · Cited by 700 · cited 2×
“7 times increased rate of infection (13).”
BackgroundUmpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Self-citationHyperglycemic Crises in Adult Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., & Kreisberg, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-9916 · Cited by 512
Self-citationManagement of Hyperglycemia in the Hospital Setting
Inzucchi, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060094 · Cited by 391
Cited by
Items 501–600 of 733
Cuervo, C. G., Morla, A. S., Asín, M. A. P., Pardo, O. B., Ordoño, L. P., & Santos, J. V. (2016) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2016.04.004 · Cited by 3
María, M. A. M., Ramos, A., Roldán, M. J. M., Giménez, I., & Pérez, A. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.07.010 · Cited by 3
Management of Severe/Acute Hyperglycemia in Hospitalised Type 2 Diabetes Mellitus Patients
Huri (2013) · Journal of Endocrinology and Diabetes Mellitus · doi:10.12970/2310-9971.2013.01.01.3 · Cited by 4
Implementation of an inpatient hyperglycemia management program incorporating a nurse consultant
María, M. A. M., Ramos, A., Roldán, M. J. M., Giménez, I., & Pérez, A. (2020) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2020.08.012 · Cited by 3
Yago, G., Venturas, M., Blanco, J., Pérez, I., Falces, C., Roqué, M., Yugueros, X., Cardete, L., Renú, A., Caellas, D., et al. (2022) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2021.09.018 · Cited by 4
Management of Patients with Diabetes in the Intensive Care Unit
Cieślak, J., Levin, A., & Beaulieu, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00215-6 · Cited by 4
Sternthal, E., UNDERWOOD, P. C., & Mantzoros, C. S. (2015) · Metabolism · doi:10.1016/j.metabol.2015.06.012 · Cited by 3
Velasco, M. Á. P., Osuna‐Sánchez, J., Millán‐Gómez, M., Ricci, M., Sampalo, A. L., Bernal-López, M. R., Gómez‐Huelgas, R., & Perez-Belmonte, L. M. (2024) · Medicina Clínica · doi:10.1016/j.medcli.2024.10.021 · Cited by 2
Kanbour, S., Zale, A. D., Shim, J., Abusamaan, M. S., & Mathioudakis, N. N. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.01.008 · Cited by 2
Ammar, A., Sorochak, N., Paxton, R. A., Lipari, M., & Giuliano, C. A. (2025) · Journal of Intensive Care Medicine · doi:10.1177/08850666251371709 · Cited by 2
“23 More recent evidence from a study in surgical ICU (SICU) patients without a history of diabetes showed that long-acting insulin (LAI) in addition to SSI increased the risk of hypoglycemia compared to SSI alone.”
Perez-Belmonte, L. M., Prieto-Laín, N., Trenas, A., & Gómez-Huelgas, R. (2026) · Revista Clínica Española · doi:10.1016/j.rce.2026.502491 · Cited by 3
Glycaemic management in patients with diabetes in hospital
Rajendran, R., & Rayman, G. A. (2014) · Medicine · doi:10.1016/j.mpmed.2014.09.010 · Cited by 3
Ambulatory anesthesia: optimal perioperative management of the diabetic patient
Polderman, J. A. W., van Wilpe, R., Eshuis, J. H., Preckel, B., & Hermanides, J. (2016) · Ambulatory Anesthesia · doi:10.2147/aa.s102136 · Cited by 3
“15,18 The underlying pathophysiologic mechanisms by which hyperglycemia leads to an increase in deleterious outcomes have not yet been fully elucidated.”
Evaluation of Insulin Use and Hypoglycemia in Hospitalized Elderly Patients
Bach, Q. N., Gilmore, R. A., Sheffield, M. C., & Hawkins, W. A. (2017) · Hospital Pharmacy · doi:10.1177/0018578717735974 · Cited by 3
“reported that 23% of surgical patients with diabetes mellitus who received a basal-bolus insulin regimen developed hypoglycemia.(23) Furthermore, Farrokhi et al.”
BackgroundClosed-loop management of inpatient hyperglycaemia
Boughton, C. K., & Hovorka, R. (2019) · British Journal of Hospital Medicine · doi:10.12968/hmed.2019.80.11.665 · Cited by 2
Mitra, A., Ray, S., & Jayan, S. (2021) · Clinical Diabetology · doi:10.5603/dk.a2021.0011 · Cited by 3
“A different study in general surgery patients also compared efficacy and safety of a basal bolus regimen to SSI in patients with type 2 diabetes [17].”
BackgroundDiabetes workshops for providers improve glucose control in coronary artery bypass grafting patients
Bogun, M. M., Beier, M. A., Singh, S. K., McLaughlin, D., Ning, Y., Kurlansky, P. A., & Raza, S. T. (2022) · Journal of Cardiac Surgery · doi:10.1111/jocs.16282 · Cited by 2
Risk of postoperative complications in hyperglycemic conditions
Kremenchugskaya, T. A., Va, K., & Samokhodskaya, L. M. (2022) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia202301167 · Cited by 2
Dei, A., Aldigeri, R., Ridolfi, V., Vazzana, A., Ciardullo, A. V., Manicardi, V., Sforza, A., Tomasi, F., Zavaroni, D., Zavaroni, I., et al. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3708 · Cited by 2
“24,25 Despite the heightened awareness of the importance of a strict inpatient glucose control to improve clinical outcomes in all settings including elective surgery, 26 intensive care 27 and internal medicine units, 11 this hardly ever translates into improved glycaemic management strategies.”
BackgroundClinical Practice Update: Inpatient Insulin Pump and Integrated Insulin Delivery Systems
Nguyen, S., Davis, G. M., & Vasudevan, M. M. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-44648-1_7 · Cited by 2
Leal, J., Wellman, S. S., Jiranek, W. A., Seyler, T. M., Bolognesi, M. P., & Ryan, S. P. (2024) · Orthopedics · doi:10.3928/01477447-20240619-02 · Cited by 2
Endocrine Care for the Surgical Patient
Mendez, C. E., Shiffermiller, J. F., Razzeto, A., & Hannoush, Z. C. (2024) · Medical Clinics of North America · doi:10.1016/j.mcna.2024.04.007 · Cited by 2
Effects of APOE isoforms in diabetic nephropathy patients of South India
Basavaraju, P., Moorthi, P. V., Meyyazhagan, A., Devaraj, I., Babu, K., Panza, E., & Orlacchio, A. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02374-2 · Cited by 2
“At clinical levels DN is characterized by specific changes in kidney structure and function, including progressive decline in renal functions and persistent albuminuria [3 –5 ].”
Luo, Y., Xiao-min, N., Yao, W., Wang, W., Li, Y., Lv, Q., Ding, W., & Tang, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-78343-0 · Cited by 3
Susan, S.-F. G., Clark, L., Dacenko-Grawe, L., Devi, R., Diaz, J., Javadi, M., & Salinas, H. (2011) · InTech eBooks · doi:10.5772/23705 · Cited by 3
“…sliding scale treatment among general surgical patients, glycemic control was improved (mean blood glucose 145 ± 32 mg/dL vs. 172 ± 47 mg/dL, p 0.01), and a composite outcome of complications was reduced from 24.3 to 8.6%with odds ratio 3.39 (95% CI 1.50-7.65), p = 0.003 (Umpierrez et al., 2011).”
BackgroundInfluentialThe Adjectives of Inpatient Glycemic Management
Reider, J. A., & Korytkowski, M. T. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0250-7 · Cited by 2
Martínez‐Brocca, M. A., Morales, C., Rodríguez-Ortega, P., Aguilera, B., Montes, C., Colomo, N., Piédrola, G., Méndez-Muros, M., Serrano, I., de Adana, M. S. R., et al. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2014.09.006 · Cited by 4
Perioperative Glucose Management
Wei, N., & Wexler, D. J. (2012) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2012.05.002 · Cited by 2
“RABBIT2-Surgery Insulin Treatment protocol (21): 1.”
Control glucémico en el hospital. ¿Por qué no mejora?
Pérez, A. (2012) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2012.01.014 · Cited by 4
Hyperglycemia in the Intensive Care Unit
Lenhardt, R., & Akça, O. (2015) · Türk yoğun bakım derneği dergisi/Türk yoğun bakım dergisi · doi:10.4274/tybdd.03521 · Cited by 3
“The basal-bolus insulin concept has been shown to be superior to a sliding scale insulin concept to reach target blood glucose values of <140 mg/dl in both medical and surgical patients (41).”
Hudson, M., & Palermo, N. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-20317-1_14-1 · Cited by 2
Implementation of a Standardized Admission Hyperglycemia Insulin Order Set in a Veterans Hospital
Yeung, E. K. (2018) · Juniper Online Journal of Case Studies · doi:10.19080/jojcs.2018.07.555701 · Cited by 2
“guidelines, its implementation appears to have some barriers [11-14].”
BackgroundFranco, T., Rupp, S. M., Williams, B., & Blackmore, C. C. (2019) · BMJ Open Quality · doi:10.1136/bmjoq-2018-000455 · Cited by 3
Horton, W. B., Law, S., Darji, M., Conaway, M. R., Kubiak, N. T., Kirby, J. L., & Thigpen, S. C. (2019) · BMC Medical Education · doi:10.1186/s12909-019-1657-0 · Cited by 2
Management of the Inpatient with Diabetes Mellitus
Rayman, G. A. (2022) · doi:10.1093/med/9780198870197.003.0266 · Cited by 2
Ramos, A., Zapata, L., Vera, P., Betbese, A. J., & Pérez, A. (2017) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2017.11.011 · Cited by 2
Determinants of initial insulin therapy for hospitalized patients with diabetes mellitus
Chiang, H.-H., Surampudi, P. N., & Sood, A. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108307 · Cited by 3
Inpatient management of diabetes and hyperglycaemia: an audit of Spanish hospitals
Ena, J., Carretero‐Gómez, J., Rojo, J. M. C., Casado, P., Vázquez-Rodríguez, P., Martínez-García, F., González-González, P., de Escalante-Yangüela, B., Gandullo-Moro, M., & Carrasco-Sánchez, F. J. (2023) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2023.04.011 · Cited by 2
Gracia‐Ramos, A. E., Cruz-Domínguez, M. P., Madrigal‐Santillán, E., Rojas-Martínez, R., Morales‐González, J. A., Morales‐González, Á., Hernández-Espinoza, M., Vargas-Peñafiel, J., & Tapia-González, M. D. L. Á. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108742 · Cited by 2
Surgical Site Infections and Postoperative Factors
Dellinger, E. P. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1141 · Cited by 2
Regular Insulin Versus NPH Insulin for Continuous Enteral Tube Feeding in Hospitalized Patients
Kalangi, S. T., Bokka, S. M., Anand, S., & Garg, R. (2025) · Clinical Diabetes · doi:10.2337/cd24-0103 · Cited by 1
Novel Approach to Inpatient Glucometric Monitoring and Variability in a Community Hospital Setting
Koziol, J. A., Johnson, K., Brenner, K., Fortmann, A. L., Morrisey, R., & Philis‐Tsimikas, A. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814564992 · Cited by 1
Management of Hyperglycemia in the Neurosurgery Patient
Daniel, R., Villuri, S., & Furlong, K. (2020) · JHN journal · doi:10.29046/jhnj.015.1.005 · Cited by 1
Sevoflurane-induced hyperglycemia is attenuated by salsalate in obese insulin-resistant mice
Desjardins, E. M., Smith, B. K., Steinberg, G. R., & Brown, R. E. (2021) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-021-01935-1 · Cited by 1
Derakhshan, P., Khatibi, A., Faiz, S. H. R., Rahimzadeh, P., & Nouri, N. (2021) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.35.31 · Cited by 1
Ryan, I., Herrick, C., Ebeling, M. F. E., & Foraker, R. E. (2022) · JMIR Diabetes · doi:10.2196/27486 · Cited by 1
“Basal-bolus insulin regimens for inpatient glycemic control have been shown to reduce hospital complications, particularly for postsurgical patients [10,11], with potentially improved glycemic control in subsequent follow-up periods as well [12].”
BackgroundGlycemic Management in Insulin-Naive Patients in the Inpatient Setting
Goldstein, M. B., Islam, S., Nicolich-Henkin, S., Bellavia, L., & Klek, S. P. (2024) · Diabetes Spectrum · doi:10.2337/ds23-0007 · Cited by 1
Yang, C. J., Bourgeois, C., Delgado, E., Graham, W., & Burmeister, M. A. (2024) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.3389/jpps.2024.13074 · Cited by 1
In-Hospital Management of Hyperglycemia: The Role of Insulin Degludec
WANGNOO, S. K., Baruah, M. P., Lodha, S., Sanyal, D., Goyal, R., Sooragonda, B. G., Chandrasekaran, S., & Kumar, G. V. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01707-w · Cited by 2
“Long-acting insulin analogs, such as insulin glargine (IGlar) U100 and IGlar U300, have demonstrated effectiveness in managing hyper-glycemia in hospitalized patients with T2DM, exhibiting low rates of hypoglycemic events across medical and surgical settings [4, 14, 22].”
Pacheco, S. T., Weber, F. L. R., Greene, E. J. D., & Valdivia, G. G. (2025) · Acta Médica Grupo Ángeles · doi:10.35366/119342 · Cited by 2
Evaluating Intensive Insulin Therapy With Empagliflozin in Type 2 Diabetes: A Randomised Study
Fushimi, N., Hachiya, H., Iwasaka, T., Nagao, M., Masamura, T., Higashi, K., & Mori, A. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70096 · Cited by 1
Passarella, P., & Gosmanov, A. R. (2025) · Medical Clinics of North America · doi:10.1016/j.mcna.2025.11.001 · Cited by 1
Soliman, D., Varghese, R. T., Umpierrez, G. E., & Galindo, R. J. (2025) · Medical Clinics of North America · doi:10.1016/j.mcna.2025.11.006 · Cited by 1
Self-citationGlucocorticoid‐Induced Hyperglycaemia in Hospital: The Insulin Dose Matters Most
Burt, M. G., Khalili, F., Radhakutty, A., & Chen, A. X. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70756 · Cited by 1
“Several prospective studies have reported that lowering elevated blood glucose levels can improve patient outcomes in hospital [7–9].”
Liu, Z., & Liu, Y. (2026) · Surgical Laparoscopy Endoscopy & Percutaneous Techniques · doi:10.1097/sle.0000000000001467 · Cited by 1
Camuto, P., Guadagnini, D., Assalin, H. B., Magro, D. O., Santos, A., & Saad, M. J. A. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.06.010 · Cited by 1
Umpierrez, G. E., Orobio, C., Petty, K. B., Nalabolu, S., Oladejo, O., & Vellanki, P. (2026) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2026-006596 · Cited by 1
Self-citationInsulinoterapia en situaciones especiales. Diabetes y cirugía
López, A. H., Meneses, A. L., Toboso, R. P. Q., & Moreno, I. H. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70434-1 · Cited by 1
Prise en charge du diabète en milieu hospitalier
Houlden, R. L., Capes, S. E., CLEMENT, M. A., & Miller, D. B. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.008 · Cited by 1
Glycemic control at hospital: Why does it not improve?
Pérez, A. (2012) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2012.04.003 · Cited by 1
Roderman, N. S., Haire, S., & Hawley, D. (2014) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2014-1371 · Cited by 1
Roberts, G. W., & Godbole, G. (2015) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1134 · Cited by 1
Diabetes and Hyperglycemia in the Surgical Setting
DeFelice, N., & Thompson, R. E. (2016) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2015.11.006 · Cited by 1
Assuring epidemiological safety for healthcare of patients with diabetes mellitus
Dedov, I. I., Briko, N. I., Андрианова, Е. А., Abramova, I. M., Брусина, Е. Б., Bunova, A., Dementieva, L. A., Игонина, Е. П., Karpushkina, A. V., Kravchuk, S. V., et al. (2016) · Problems of Endocrinology · doi:10.14341/probl201662333-60 · Cited by 1
Cook, C. B., Apsey, H. A., Glasgow, A. E., Castro, J. C., Habermann, E. B., & Schlinkert, R. T. (2017) · Future Science OA · doi:10.4155/fsoa-2017-0099 · Cited by 1
Management of Diabetes and/or Hyperglycemia in Non‐Critical Care Hospital Settings
Galindo, R. J., & Umpierrez, G. E. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch30 · Cited by 2
Self-citationAlfehaid, L., Alotaibi, A. S., Alanazi, A. S., Bustami, R. T., & Melik, R. M. E. (2018) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2018.94023 · Cited by 1
“Recent randomized clinical trials showed that the use of BBI proved to be more effective than SSI in terms of achieving the desired blood glucose levels in hospitalized patients with type 2 diabetes [10] [11].”
Diabetes in Kidney Transplant Recipients
Dhital, S. M. (2018) · Springer eBooks · doi:10.1007/978-3-030-00132-2_10 · Cited by 1
Alzueta, G., Bauchi, J. C., Dieuzeide, G., Rímoli, D., Suárez, R., Sosa, A., Santillán, C., Linares, M., Denaro, R., Zarza, G., et al. (2018) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v52i2.117 · Cited by 1
Insulin Treatment in Hospitalized Patients
Moon, S. J., & Cho, Y. M. (2018) · Journal of Korean Diabetes · doi:10.4093/jkd.2018.19.4.214 · Cited by 1
Miscellaneous Complications Related to Hematopoietic Cell Transplantation
Saif, M. A., & Dignan, F. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-56802-9.00024-9 · Cited by 2
Brunke-Reese, D., Ssentongo, P., Ssentongo, A. E., Phillips, B. E., Pauli, E. M., Berg, A. S., Kelleher, S. L., & Soybel, D. I. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02588 · Cited by 1
Inpatient Management of Diabetes and Hyperglycemia
Horton, W. B. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_43 · Cited by 1
Management of Routine Surgery in Diabetes
Kelkar, S., Muley, S., & Ambardekar, P. (2019) · Springer eBooks · doi:10.1007/978-981-13-7705-1_6 · Cited by 1
Management of diabetes in patients with coronavirus disease 2019: A practical approach
Eledrisi, M. S., & Elzouki, A.-N. Y. (2020) · Libyan Journal of Medical Sciences · doi:10.4103/ljms.ljms_34_20 · Cited by 1
Peña-Valenzuela, A. N., Flores-Montes, G. V., Inzunza-Cervantes, G., Ornelas-Aguirre, J. M., Ponce-Peraza, M. A., & López-López, R. M. (2021) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.20000095 · Cited by 4
“De manera general las diferentes guías internacionales recomien-dan en pacientes críticos el uso de insulina en infu-sión intravenosa continua y en los pacientes hospitalizados no críticos, el uso de esquemas subcutáneos, siendo el esquema de insulina basal-bolo (prandial) el de elección 31-34 .”
Inpatient Management of Type 2 Diabetes Mellitus
Lee, H. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-84367-0_41 · Cited by 1
Uso inicial de insulina en pacientes hospitalizados con diabetes mellitus tipo 2
Díaz, J. J. S., Arias, L. O. M., Murcia, A. M. P., Díaz, A. L. A., Ângulo, P. S., Roa, D. E. M., & Orjuela, A. M. (2022) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.8.4.714 · Cited by 1
Perioperative Care of the Orthopedic Patient with Diabetes Mellitus
Gregory, N. S., & MacKenzie, C. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-35570-8_16 · Cited by 1
Chen, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-19704-9_13 · Cited by 1
Dowlatshahi, S., Patham, B., Shakil, J., Zahid, M., Arunchalam, P., Kansara, A., & Sadhu, A. (2022) · Diabetes Spectrum · doi:10.2337/dsi22-0012 · Cited by 1
Disease Staging: Prevalence of Cardiorespiratory Complications in Type 2 Diabetes Mellitus
Carrondo, M. C. (2022) · Clinical Medicine & Research · doi:10.3121/cmr.2022.1699 · Cited by 1
Ghazi, H. A., Hegazy, A., & Nowara, A. S. (2023) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2023.279618 · Cited by 1
Webster, R. E., Belfer, J. J., & Schmidt, K. J. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280231197255 · Cited by 1
“25,26 Contrary to those findings, in our analysis of critically ill patients without preexisting diabetes, we found lower glycemic variability in those who received SSI compared with BPI.”
ResultPreoperative Management of Diabetic Patients Undergoing Abdominal Surgery
Zeb, M., Khattak, J. A., Sikander, S., ., M., Munir, M., Jamal, M. A., & Khan, N. A. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023176332 · Cited by 1
Fukuda, Y., Ushigome, E., Yamazaki, M., & Fukui, M. (2024) · Vascular Health and Risk Management · doi:10.2147/vhrm.s447077 · Cited by 2
“10 The authors of the above mentioned study focused on the difference in the pathophysiology of valvular diseases and coronary artery disease.”
BackgroundPrinciples of Care in the Diabetic Surgical Patient
Khazai, N. B., & Hamdy, O. (2024) · Contemporary diabetes · doi:10.1007/978-3-031-55715-6_6 · Cited by 1
Evaluation of pharmacist‐initiated glycemic control in adult medicine patients with diabetes
Wells, D. A., Sakaan, S. A., Shaver, J., Cutshall, B. T., & Twilla, J. D. (2024) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.2072 · Cited by 1
“3,10 There were no differences between the two groups in mean daily BG nor rates of hypo-glycemic events.”
Perioperative Care of the Orthopedic Patient with Diabetes Mellitus
MacKenzie, C. R., & Gregory, N. S. (2014) · Springer eBooks · doi:10.1007/978-1-4614-0100-1_14 · Cited by 1
Intensive Insulin Therapy in Hospitalized Patients
Korytkowski, M., Moghissi, E. S., & Umpierrez, G. E. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-12-201106210-00021 · Cited by 1
Self-citationIn-Hospital Hyperglycemia: Quo Vadis?
Sechterberger, M. K., Siegelaar, S. E., & DeVries, J. H. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0177 · Cited by 2
“The blood glucose values achieved in the RABBIT 2 surgery trial 28 indicate that these targets are not easily met, and there is a lack of evidence to support the treatment of patients without diabetes on the ward with insulin.”
Upcoming Trends for Inpatient Diabetes Management
Clement, S. C. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0404 · Cited by 1
“We now have evidence that basal-bolus insulin therapy is superior to standard ‘‘sliding scale’’ for maintaining hospital glucose control.(4) Tool kits and review articles are available that allow clinicians and hospitals to implement sound hospital glucose management.”
BackgroundPerioperative management of diabetes mellitus: a review
Azevedo, M. R. M. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/51g4-s642 · Cited by 1
The Effect of Enhanced Recovery After Surgery (ERAS®) on Individuals with Diabetes
Albalawi, Z. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r34q7r59p · Cited by 1
Inpatient management of diabetes and hyperglycemia
Seggelke, S. A., & Draznin, B. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4975-1.00013-9
Medication safety for surgical patients
Spell, N. O. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511920660.007
Hyperglykämiemanagement in der Notaufnahme
Zelihic, E., & Siegmund, T. (2015) · CardioVasc · doi:10.1007/s15027-015-0639-3
“Ein solches rein reaktives Insulinkorrekturschema („SlidingScale-Schema“) wird dem eigentlichen Bedarf des Patienten nicht gerecht, da dem vorhandenen Insulinde«zit in dieser akuten Phase nur durch den kombinierten Einsatz eines zusätzlichen Basalinsulins adäquat begegnet werden kann [38, 39].”
BackgroundBertrand, M., Conil, J.-M., Georges, B., Hanaire, H., & Bertrand, M. (2012) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(12)70356-5
PERIOPERATIVE CONTROL OF BLOOD GLUCOSE
Kuşkonmaz, Ş. M., & Arslan, M. (2015) · Medical Science and Discovery · doi:10.17546/msd.33131
Riesgos y beneficios del tratamiento de la hiperglucemia en el paciente hospitalizado no crítico
Botella-Serrano, M. (2012) · Avances en Diabetología · doi:10.1016/j.avdiab.2012.09.004 · Cited by 2
Metadata
- Authors
- Umpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M.
- Affiliations
- Grady Memorial Hospital (US)
- Emory University (US)
- Department of Medicine, Emory University, Atlanta, Georgia
- Corresponding author
- Umpierrez, Guillermo E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-01-20
- Volume
- 34
- Issue
- 2
- Pages
- 256-261
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3024330
- OpenAlex
- W2106327047
- Cited by
- 720
- References
- 24
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 37 · 2023: 47 · 2022: 53 · 2021: 37 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 54 · 2016: 48 · 2015: 51 · 2014: 61 · 2013: 53 · 2012: 44
- FWCI
- 48.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000454)
- National Institute of Diabetes and Digestive and Kidney Diseases (R03DK073190)
- National Center for Research Resources (M01-RR00039, K12RR017643, M01RR000039)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, multiple daily insulin injections, glargine, glulisine, sliding scale insulin, general surgery, perioperative hyperglycemia, glycemic control, postoperative complications, wound infection, respiratory failure, acute kidney injury, bacteremia
- MeSH terms
- Insulin Glargine, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Inpatients, Insulin, Male, Middle Aged, Postoperative Complications, Prospective Studies, General Surgery, Perioperative Care, Insulin, Long-Acting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.